Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy

Abstract excerpt

Genomic alterations may make cancer cells more dependent than normal cells on mechanisms of proteostasis, including protein folding and degradation. This proposition is the basis for the clinical use of proteasome inhibitors to treat multiple myeloma and mantle cell lymphoma. However, proteasome inhibitors have not proved effective in treating other cancers, and this has called into question the general...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Ubiquitin and proteasome pathways
• Share to Peptidase Inhibition and Analysis
• Share to Protein Degradation and Inhibitors